ACC 22: Results from a sub-study of the POISE-3 Trial | Dr Maura Marcucci

Подробнее о видео

Watch the full video on Radcliffe Cardiology here:

In this short interview from our coverage of the ACC 22 late-breaking trials, Dr Maura Marcucci (McMaster University, ON, CA) discusses a sub-study of the POISE-3 trial, which sought to evaluate the effects of a perioperative hypotension-avoidance strategy, compared to a hypertension-avoidance strategy on the risk of acute kidney injury in patients undergoing non-cardiac surgery (NCT03505723).

Discussion Points:

Study objectives
Study design and patient cohort
Study results
Take-home messages for clinicians
Further study recommendations

Recorded remotely from ACC, Washington DC, 2022.
Interviewer: Mirjam Boros

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.